DTRT HEALTH ACQUISITION CORP. Item 7.01 Regulation FD Disclosure
Attached as Exhibit 99.1 hereto and incorporated herein by reference is an
investor presentation dated
The information in this Item 7.01, including Exhibit 99.1, is furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to liabilities under that section, and shall not be deemed to be incorporated by reference into the filings of DTRT under the Securities Act or the Exchange Act, regardless of any general incorporation language in such filings. This Current Report on Form 8-K will not be deemed an admission as to the materiality of any information of the information in this Item 7.01, including Exhibit 99.1.
Participants in Solicitation
DTRT and its directors and executive officers may be deemed participants in the
solicitation of proxies from DTRT's stockholders with respect to the Business
Combination. A list of the names of those directors and executive officers and a
description of their interests in DTRT is contained in DTRT's Annual Report on
Form 10-K for the fiscal year ended
CDH and its directors and executive officers may also be deemed to be participants in the solicitation of proxies from the stockholders of DTRT in connection with the Business Combination. A list of the names of such directors and executive officers and information regarding their interests in the Business Combination will be contained in the Registration Statement when available.
Forward-Looking Statements
This Current Report on Form 8-K includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. DTRT's and CDH's actual results may differ from their expectations, estimates and projections and consequently, you should not rely on these forward looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, DTRT's and CDH's expectations with respect to future performance and anticipated financial impacts of the Business Combination, the satisfaction of the closing conditions to the Business Combination and the timing of the completion of the Business Combination. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Most of these factors are outside DTRT's and CDH's control and are difficult to predict. Factors that may cause such differences include, but are not limited to: (i) the occurrence of any event, change or other circumstances that could give rise to the termination of the Merger Agreement or could otherwise cause the transactions contemplated therein to fail to close; (ii) the outcome of any legal proceedings that may be instituted against DTRT, CDH, CDCN or others following the announcement of the Business Combination and any definitive agreements with respect thereto; (iii) the inability to complete the Business Combination due to the failure to obtain approval of the stockholders of DTRT or CDH; (iv) the inability of CDH to satisfy other conditions to closing; (v) changes to the proposed structure of the Business Combination that may be required or appropriate as a result of
1
--------------------------------------------------------------------------------
applicable laws or regulations or as a condition to obtaining regulatory
approval of the business combination; (vi) the ability to meet stock exchange
listing standards in connection with and following the consummation of the
proposed Business Combination; (vii) the risk that the proposed Business
Combination disrupts current plans and operations of CDH as a result of the
announcement and consummation of the proposed Business Combination; (viii) the
ability to recognize the anticipated benefits of the Business Combination, which
may be affected by, among other things, competition, the ability of CDCN to grow
and manage growth profitably, the ability of CDCN to maintain relationships with
customers, suppliers, labor unions and other organizations that have a role in
the business of CDH and the ability of CDCN to retain its management and key
employees; (ix) costs related to the Business Combination; (x) changes in
applicable laws or regulations, including those affecting in-home healthcare;
(xi) the possibility that CDH or CDCN may be adversely affected by other
economic, business, regulatory, and/or competitive factors; (xii) CDH's
estimates of expenses and profitability; (xiii) the evolution of the markets in
which CDH competes; (xiv) the ability of CDH to implement its strategic
initiatives and continue to innovate its existing offerings; (xv) the ability of
CDH to satisfy regulatory requirements; (xvi) the impact of the COVID-19
pandemic on CDH's and CDCN's business; and (xvii) other risks and uncertainties
set forth in the section entitled "Risk Factors" and "Cautionary Note Regarding
Forward-Looking Statements" in DTRT's Annual Report on Form 10-K for the fiscal
year ended
No Offer or Solicitation
This Current Report on Form 8-K is not intended to and shall not constitute a proxy statement or the solicitation of a proxy, consent or authorization with respect to any securities in respect of the Business Combination and shall not constitute an offer to sell or the solicitation of an offer to buy or subscribe for any securities or a solicitation of any vote of approval, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits
The following exhibit is furnished with this report.
Exhibit No. Description 99.1 Investor Presentation datedOctober 2022 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2
--------------------------------------------------------------------------------
© Edgar Online, source
